Risk factors for treatment failure in scabies: a cohort study

被引:32
|
作者
Aussy, A. [1 ,2 ]
Houivet, E. [3 ,4 ]
Hebert, V. [1 ,2 ]
Colas-Cailleux, H. [1 ,2 ]
Laaengh, N. [1 ,2 ]
Richard, C. [1 ,2 ]
Ouvry, M. [1 ,2 ]
Boulard, C. [1 ,2 ]
Leger, S. [1 ,2 ]
Litrowski, N. [1 ,2 ]
Benichou, J. [3 ,4 ]
Joly, P. [1 ,2 ]
Bechu, S.
Mion-Mouton, N.
Lafaurie, O.
Barrel, A.
Pulluard, M.
Hamel, V.
Dore, M. X.
Duflo, E.
Lardans-Cassius, S.
Rzeznik, J. C.
Baricault, S.
机构
[1] Rouen Univ Hosp, Dept Dermatol, Rouen, France
[2] Univ Rouen Normandie, INSERM, U1234, Rouen, France
[3] Rouen Univ Hosp, Dept Biostat, Rouen, France
[4] Univ Rouen Normandie, INSERM, U1219, Rouen, France
关键词
ORAL IVERMECTIN; PREVALENCE; EPIDEMIOLOGY; CREAM;
D O I
10.1111/bjd.17348
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Treatment failure, which occurs in about one-third of cases, is considered as a major factor in the increasing incidence of scabies in developed countries. Objectives To identify predictors of treatment failure of scabies in ambulatory populations. Methods This multicentre study compared the clinical characteristics and treatment modalities between a group of patients with scabies treated successfully and another group who were not cured 3 months after antiscabies treatment. Results In total 210 patients with a diagnosis of scabies were included, comprising 98 patients in the treatment success group and 112 in the treatment failure group. The main risk factors for treatment failure were (i) the use of only one type of treatment, topical benzyl benzoate (BB) or oral ivermectin, vs. the combination of both treatments [odds ratio (OR) 2 center dot 15, 95% confidence interval (CI) 1 center dot 22-3 center dot 77]; (ii) the use of a single intake (vs. two) of oral ivermectin (OR 10 center dot 2. 95% CI 4 center dot 49-23 center dot 2); (iii) intake of ivermectin during a meal vs. on an empty stomach (OR 4 center dot 31, 95% CI 1 center dot 89-9 center dot 84); (iv) absence of decontamination of furnishings (OR 8 center dot 72, 95% CI 3 center dot 50-21 center dot 8), in particular sofa and cushions (OR 5 center dot 90, 95% CI 2 center dot 34-14 center dot 9), mattresses (OR 4 center dot 16, 95% CI 1 center dot 35-12 center dot 8) or car seats (OR 6 center dot 57, 95% CI 3 center dot 27-13 center dot 2) and (v) absence of written documents explaining treatment modalities (OR 5 center dot 18, 95% CI 2 center dot 57-10 center dot 4). In multivariate analysis, treatment failure was mainly associated with (i) use of a single intake (vs. two) of ivermectin (OR 6 center dot 62, 95% CI 2 center dot 71-16 center dot 2); (ii) use of BB alone vs. two intakes of ivermectin (OR 3 center dot 51, 95% CI 1 center dot 55-7 center dot 95) and (iii) absence of decontamination of furniture with acaricides (OR 5 center dot 81, 95% CI 1 center dot 96-16 center dot 7). Conclusions Use of topical BB alone and a single intake (vs. two) of ivermectin are predictors of treatment failure.
引用
收藏
页码:888 / 893
页数:6
相关论文
共 50 条
  • [2] Risk factors for scabies treatment resistance: a retrospective cohort study
    Lee, S. K.
    Kim, J. H.
    Kim, M. S.
    Lee, U. H.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (01) : 126 - 132
  • [3] Risk factors for nodal failure in the EMBRACE study cohort
    Peters, M.
    De Leeuw, A. A. C.
    Poetter, R.
    Nomden, C. N.
    Tanderup, K.
    Kirchheiner, K.
    Schmid, M. P.
    Fortin, I.
    Haie-Meder, C.
    Lindegaard, J. C.
    Sturdza, A.
    Mahantshetty, U.
    Hoskin, P.
    Segedin, B.
    Bruheim, K.
    Rai, B.
    Huang, F.
    Cooper, R.
    Van der Steen-Banasik, E.
    Van Limbergen, E.
    Nout, R.
    Juergenliemk-Schulz, I.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S315 - S316
  • [4] The risk factors for failure of labor induction: A cohort study
    Giugliano E.
    Cagnazzo E.
    Milillo V.
    Moscarini M.
    Vesce F.
    Caserta D.
    Marci R.
    The Journal of Obstetrics and Gynecology of India, 2014, 64 (2) : 111 - 115
  • [5] Risk factors for methotrexate treatment failure in tubal ectopic pregnancy: a retrospective cohort study
    Fu, Linru
    Liu, Xinyan
    Tian, Zhao
    Du, Zhe
    Wang, Xinyi
    Wang, Xiuqi
    Li, Xiaodong
    Xu, Tao
    Sun, Zhijing
    BMC PREGNANCY AND CHILDBIRTH, 2024, 24 (01)
  • [6] Treatment failure for scabies
    Krome, Susanne
    AKTUELLE DERMATOLOGIE, 2024, 50 (05) : 208 - 208
  • [7] FAILURE OF SCABIES TREATMENT
    LEIBOWITZ, MR
    NEW ZEALAND MEDICAL JOURNAL, 1993, 106 (960) : 317 - 318
  • [8] Unveiling Risk Factors for Treatment Failure in Patients with Graves' Disease: A Nationwide Cohort Study in Korea
    Kim, Jung A.
    Kim, Kyeong Jin
    Choi, Jimi
    Kim, Kyoung Jin
    Song, Eyun
    Yu, Ji Hee
    Kim, Nam Hoon
    Yoo, Hye Jin
    Seo, Ji A.
    Kim, Nan Hee
    Choi, Kyung Mook
    Baik, Sei Hyun
    Kim, Sin Gon
    ENDOCRINOLOGY AND METABOLISM, 2025, 40 (01) : 125 - 134
  • [9] Risk Factors for Treatment Failure in Neonates With Skin and Soft Tissue Infection: A Retrospective Cohort Study
    Patel, Purva
    Foster, Catherine E.
    Stimes, Grant
    Lee, Su Rin
    Wallace, Sowdhamini S.
    CLINICAL PEDIATRICS, 2024, 63 (05) : 689 - 696
  • [10] Glyburide treatment of A2 gestational diabetes in a large cohort study: risk factors for failure
    Misiak, Kristen
    Darbinian, Jeanne A.
    Ching, Jenny Y.
    Jacobson, Gavin F.
    Regenstein, Anne C.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 214 (01) : S92 - S92